ZA727362B - Novel pyrimidinones and novel hydroxy pyrimidines - Google Patents

Novel pyrimidinones and novel hydroxy pyrimidines

Info

Publication number
ZA727362B
ZA727362B ZA727362A ZA727362A ZA727362B ZA 727362 B ZA727362 B ZA 727362B ZA 727362 A ZA727362 A ZA 727362A ZA 727362 A ZA727362 A ZA 727362A ZA 727362 B ZA727362 B ZA 727362B
Authority
ZA
South Africa
Prior art keywords
novel
pyrimidinones
hydroxy pyrimidines
pyrimidines
hydroxy
Prior art date
Application number
ZA727362A
Other languages
English (en)
Inventor
C Lipinski
J Stam
G Deangelis
H Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA727362B publication Critical patent/ZA727362B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA727362A 1971-10-29 1972-10-16 Novel pyrimidinones and novel hydroxy pyrimidines ZA727362B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (1)

Publication Number Publication Date
ZA727362B true ZA727362B (en) 1973-11-28

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA727362A ZA727362B (en) 1971-10-29 1972-10-16 Novel pyrimidinones and novel hydroxy pyrimidines

Country Status (25)

Country Link
JP (2) JPS5337870B2 (fr)
AR (2) AR198798A1 (fr)
AT (2) AT321308B (fr)
AU (1) AU467600B2 (fr)
BE (1) BE790125A (fr)
CA (1) CA980778A (fr)
CH (2) CH555832A (fr)
DE (3) DE2248741C3 (fr)
DK (1) DK131465B (fr)
EG (1) EG11013A (fr)
ES (2) ES407730A1 (fr)
FI (1) FI55503C (fr)
FR (1) FR2157865B1 (fr)
GB (2) GB1377308A (fr)
IE (1) IE37043B1 (fr)
IL (2) IL40458A (fr)
LU (1) LU66304A1 (fr)
NL (1) NL166470C (fr)
NO (1) NO136574C (fr)
PH (2) PH10129A (fr)
PL (2) PL89852B1 (fr)
SE (2) SE393376B (fr)
SU (2) SU498908A3 (fr)
YU (2) YU35125B (fr)
ZA (1) ZA727362B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (fr) * 1979-04-17 1980-11-01
JPS5752409Y2 (fr) * 1979-11-05 1982-11-15
DE3222914A1 (de) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPH0655686B2 (ja) * 1988-08-30 1994-07-27 宇部興産株式会社 ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法
KR101452518B1 (ko) 2005-08-22 2014-10-21 멜리어 파마슈티칼스 아이, 인코포레이티드 Ｌｙｎ 키나제 활성의 조절 및 관련된 장애의 치료를 위한방법 및 제제
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (fr) 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prévention de la dégénérescence des cellules pancréatiques bêta
CN110785170B (zh) 2017-04-10 2023-03-28 梅里奥尔医药I公司 脂肪细胞的治疗

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
PL84634B1 (fr) 1976-04-30
DK131465B (da) 1975-07-21
DE2264374C3 (de) 1981-07-23
IL40458A (en) 1976-05-31
FI55503B (fi) 1979-04-30
DE2264374B2 (de) 1980-08-07
DE2248741B2 (de) 1974-11-14
NL166470C (nl) 1981-08-17
SE7505279L (sv) 1975-05-06
NO136574C (no) 1977-09-28
DE2248741C3 (de) 1975-06-26
CH555832A (fr) 1974-11-15
JPS5422995B2 (fr) 1979-08-10
FI55503C (fi) 1979-08-10
LU66304A1 (fr) 1973-05-03
IL48790A (en) 1976-05-31
SE397090B (sv) 1977-10-17
AU467600B2 (en) 1975-12-04
JPS5337870B2 (fr) 1978-10-12
NL7213959A (fr) 1973-05-02
SU498908A3 (ru) 1976-01-05
DK131465C (fr) 1975-12-08
PH10129A (en) 1976-09-02
SU505362A3 (ru) 1976-02-28
DE2264657A1 (de) 1974-06-20
YU36295B (en) 1982-06-18
FR2157865A1 (fr) 1973-06-08
DE2248741A1 (de) 1973-05-03
IE37043L (en) 1973-04-29
BE790125A (fr) 1973-04-16
PH11594A (en) 1978-03-31
IE37043B1 (en) 1977-04-27
JPS53116386A (en) 1978-10-11
AT321308B (de) 1975-03-25
SE393376B (sv) 1977-05-09
YU35125B (en) 1980-09-25
AR198798A1 (es) 1974-07-24
DE2264657C2 (de) 1982-09-16
AT320656B (de) 1975-02-25
IL40458A0 (en) 1972-11-28
AR196263A1 (es) 1973-12-10
CH549579A (fr) 1974-05-31
NO136574B (fr) 1977-06-20
YU255172A (en) 1980-03-15
DE2264374A1 (de) 1973-05-24
AU4722872A (en) 1974-04-04
PL89852B1 (fr) 1976-12-31
FR2157865B1 (fr) 1975-10-31
ES436624A1 (es) 1977-02-01
GB1377308A (en) 1974-12-11
CA980778A (en) 1975-12-30
YU99179A (en) 1981-08-31
EG11013A (en) 1976-11-30
NL166470B (nl) 1981-03-16
ES407730A1 (es) 1976-01-16
IL48790A0 (en) 1976-03-31
GB1377720A (en) 1974-12-18
JPS4852780A (fr) 1973-07-24

Similar Documents

Publication Publication Date Title
AU4357772A (en) Taximeters
MY7500266A (en) Panel member
ZA727362B (en) Novel pyrimidinones and novel hydroxy pyrimidines
IE35376B1 (en) Pyrimidine derivatives
JPS5598103A (en) Novel quinazolinone herbicide
MY7600125A (en) Novel pyrimidine sulphamates their preparation and use
ZA726099B (en) Isopropylamino pyrimidine derivatives
CA1003855B (en) 1-hydrocarbyldithio-3-aryl ureas
GB1389466A (en) Door retainer
ZA715366B (en) Substituted uracils
ZA711152B (en) Manufacture of pyrimidines
AU4493472A (en) 2-nitroamino-6-hydroxy-4-methyl pyrimidines
IL37565A0 (en) 6-(4-oxopentyl)-tetrahydropyranes and their preparation
ZA739661B (en) New pyrimidines
IL39354A0 (en) 2,5-bis-substituted pyrimidines and their preparation
IE36500L (en) Quinazoline
PH9305A (en) Trialkoxy quinazolines
GB1362037A (en) Tiles
CA860328A (en) Arabinofuranosyl pyrimidines
CA860327A (en) Arabinofuranosyl pyrimidines
CA831985A (en) 2-methoxy-4-(n4-glutarylsulfanilamido) quinazoline
AU458379B2 (en) Trialkoxy quinazolines
CA887647A (en) 2-amino pyrimidines and their production
AU3531771A (en) Insect-screen doors and the like
AU2783271A (en) Trialkoxy quinazolines